"On Friday, the Food and Drug Administration placed three models of the company's implantable cardioverter defibrillators (ICDs) in its highest risk category.
"The FDA's Class I ranking means users of the device could suffer death or serious injury if the device fails. Guidant advised physicians about the possibility of problems with the devices last week." [startribune.com]
